Resources
Your Cold Chain hub for the latest trends, facts, and resources.
Read about the latest industry insights
No one should accept “good enough” for pharmaceutical cold-chain
Cihan Likogullari, head of EMEA at Envirotainer, explains the four pillars of success on which active cold-chain rest and why taking a “good enough” approach is not acceptable.
How pharma can save money and be friendlier to the planet
In the pharma industry, approximately 90% of all carbon emissions are generated in the manufacturing phase. The biggest positive impact on carbon emissions the secure cold chain can have is therefore to ensure that every single dose that is manufactured reaches the patient securely and on time.
Why pharma should spend an hour or two on Total Landed Cost
When shipping vaccines or any other temperature-sensitive medical solution, pharmaceutical companies look for partners that ensure high quality, that can simplify the handling process, and help to reduce CO2 emissions. While active temperature-controlled solutions meet all those requirements, the general perception is that they are more expensive. That perception sometimes makes pharmaceutical companies choose other, seemingly less costly alternatives, commonly known as passive solutions, not realizing that they are in essence, paying more for an inferior solution.
Dictionary
Are you familiar with the cold chain linguistics? Numerous abbreviations and internal phrases are used every day in the cold chain industry. To increase your knowledge of the industry, we will guide you through the terminology.
Frequently Asked Questions
Do you wonder about how to monitor your shipment? Or do you have questions about what languages Envirotainer Academy is held in? Here are some of the most common questions about Envirotainer cold chain products and solutions listed, together with the related answers.
